Remote Methadone Ingestion Surveillance Trial (RMIST)

University of Texas Southwestern Medical Center15 enrolled

Overview

The Remote Methadone Ingestion Surveillance Trial (RMIST) will explore a potential method of methadone ingestion surveillance that may mitigate patient safety risks of take-home methadone treatment regimens while minimizing the risk of diversion and evaluating the acceptability and feasibility of these monitoring methods. The method utilizes an innovative existing technology.

The Remote Methadone Ingestion Surveillance Trial (RMIST) aims to evaluate the performance and acceptability of a remote methadone ingestion surveillance that may mitigate the patient safety risks of take-home methadone treatment regimens for opioid use disorder (OUD) while minimizing the risk of diversion. Data describing the monitoring performance and patient acceptability of the method will inform investigators of the feasibility of using remote surveillance technology to monitor medication for OUD and mitigate treatment barriers. This study will lay the groundwork for a safe and robust remotely monitored methadone treatment platform that addresses long-standing accessibility and acceptability barriers to treatment for OUD.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Opioid Use Disorder

Interventions

RMISTOTHER

RMIST will involve: 1. A study automated visual recognition web-based platform accessible on the participant's smartphone web browser. 2. A supply of methadone in single use bottles and previously described packaging to be kept securely at the methadone clinic/lab setting.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Be male or female, 18-65 years of age * Currently receiving methadone maintenance treatment (MMT) for the treatment of opioid use disorder (OUD) * Currently receiving a take-home methadone regimen of no more than three days per week (with or without COVID-19 exceptions) * Possess an internet-connected computer or smartphone with a front facing camera. Exclusion Criteria: * Drug overdose requiring hospitalization within the last 12 months * Currently or soon to be in jail or prison; currently on probation; currently in any inpatient overnight facility as required by court of law or have pending legal action or other situation that could prevent participation in the study or in any study activities * Pregnant women * Serious psychiatric disorders that would interfere with study participation as determined by the study site Medical Clinician * Any participant that, according to the study team, may find it difficult to adhere to study procedures (e.g., no internet access, etc.) or are unable to operate the web-based platform for remote methadone ingestion

Locations (1)

UNM Addiction and Substance Abuse Program

Albuquerque, New Mexico, United States

Outcomes

Primary Outcomes

Methadone Treatment Adherence as Measured by the Number of Time-stamped Medication Consumption Events (MCE)

Methadone treatment adherence as measured by the number of time-stamped Medication Consumption Events (MCE). MCEs occur any time a participant has consumed medication as detected by the web-based monitoring platform video recording.

Time frame: Day 2 to Day 20

Platform Usability as Measured by Number of Self-reported Instances Participants Need Assistance.

Number of instances participants needed assistance from clinic or study staff to complete the remote monitoring process.

Time frame: Day 2 to Day 20

Methadone Treatment Adherence as Measured by the Number of Time-stamped Missed Detection Events (MDE).

Methadone treatment adherence as measured by the average of time-stamped Missed Detection Events (MDE). MDEs occur whenever a participant misses a dose during the dosing window and whenever there are user errors or platform issues.

Time frame: Day 2 to Day 20

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.